Rosiglitazone, a peroxisome proliferator-activated receptor-gamma ligand, reduces infarction volume and neurological deficits in an embolic model of stroke (Q48396522)

From Wikidata

Jump to navigation Jump to search

scientific article published in November 2006

Language	Label	Description	Also known as
English	Rosiglitazone, a peroxisome proliferator-activated receptor-gamma ligand, reduces infarction volume and neurological deficits in an embolic model of stroke	scientific article published in November 2006

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/17042914

Rosiglitazone, a peroxisome proliferator-activated receptor-gamma ligand, reduces infarction volume and neurological deficits in an embolic model of stroke (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/17042914

(RS)-rosiglitazone

1 reference

based on heuristic

inferred from title

author name string

Mohammad Allahtavakoli

1

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/17042914

Alireza P Shabanzadeh

2

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/17042914

Seyed Shahabeddin Sadr

3

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/17042914

Mohsen Parviz

4

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/17042914

Bijan Djahanguiri

5

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/17042914

publication date

1 November 2006

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/17042914

Clinical and Experimental Pharmacology and Physiology

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/17042914

33

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/17042914

11

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/17042914

1052-1058

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/17042914

Treatment and secondary prevention of stroke: evidence, costs, and effects on individuals and populations.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04486.X

21 January 2018

Inflammatory mediators and stroke: new opportunities for novel therapeutics

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04486.X

21 January 2018

Molecular mechanisms of glutamate-dependent neurodegeneration in ischemia and traumatic brain injury

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04486.X

21 January 2018

Pathophysiology of focal cerebral ischemia: a therapeutic perspective

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04486.X

21 January 2018

The changing landscape of ischaemic brain injury mechanisms.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04486.X

21 January 2018

Antidiabetic agent englitazone enhances insulin action in nondiabetic rats without producing hypoglycemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04486.X

21 January 2018

Troglitazone: the discovery and development of a novel therapy for the treatment of Type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04486.X

21 January 2018

Peroxisome proliferator-activated receptor-gamma ligands reduce inflammation and infarction size in transient focal ischemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04486.X

21 January 2018

Suppression of macrophage inflammatory responses by PPARs

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04486.X

21 January 2018

Troglitazone inhibits both post-glutamate neurotoxicity and low-potassium-induced apoptosis in cerebellar granule neurons

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04486.X

21 January 2018

Effect of troglitazone on fibrinolysis and activated coagulation in patients with non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04486.X

21 January 2018

Role of PPAR-gamma ligands in neuroprotection against glutamate-induced cytotoxicity in retinal ganglion cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04486.X

21 January 2018

Emerging roles of PPARs in inflammation and immunity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04486.X

21 January 2018

Peroxisome proliferator-activated receptor gamma thiazolidinedione agonists increase glucose metabolism in astrocytes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04486.X

21 January 2018

Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2 cause potent neuroprotection after experimental stroke through noncompletely overlapping mechanisms.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04486.X

21 January 2018

An improved version of embolic model of brain ischemic injury in the rat.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04486.X

21 January 2018

Thrombolysis and stroke. Past and future

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04486.X

21 January 2018

PMT13, a pyrimidone analogue of thiazolidinedione improves insulin resistance-associated disorders in animal models of type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04486.X

21 January 2018

Protective effects of statins involving both eNOS and tPA in focal cerebral ischemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04486.X

21 January 2018

Effects of nonpeptide V(1) vasopressin receptor antagonist SR-49059 on infarction volume and recovery of function in a focal embolic stroke model

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04486.X

21 January 2018

Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04486.X

21 January 2018

Actions of alpha-2 noradrenergic agonists on spatial working memory and blood pressure in rhesus monkeys appear to be mediated by the same receptor subtype

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04486.X

21 January 2018

Modification of seizure activity by electrical stimulation. II. Motor seizure

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04486.X

21 January 2018

Immunolocalization of peroxisome proliferator-activated receptors and retinoid X receptors in the adult rat CNS.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04486.X

21 January 2018

Association between diabetes and stroke subtype on survival and functional outcome 3 months after stroke: data from the European BIOMED Stroke Project

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04486.X

21 January 2018

Improvement of glucose tolerance in Zucker diabetic fatty rats by long-term treatment with the dipeptidyl peptidase inhibitor P32/98: comparison with and combination with rosiglitazone

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04486.X

21 January 2018

Dimethylsulfoxide (DMSO) treatment reduces infarction volume after permanent focal cerebral ischemia in rats

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04486.X

21 January 2018

Anesthetic methods in rats determine outcome after experimental focal cerebral ischemia: mechanical ventilation is required to obtain controlled experimental conditions

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04486.X

21 January 2018

Identifiers

10.1111/J.1440-1681.2006.04486.X

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/17042914

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/17042914

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48396522&oldid=2196808198"